Chikungunya — Precision Vaccinations

Fact checked by Robert Carlson, MD

Jun 3

4 min read

Chikungunya Vaccine Candidate Awarded $14.1 Million

Bharat Biotech BBV87 vaccine is an inactivated whole virion chikungunya vaccine

hyderabad city headquaters

Fact checked by Robert Carlson, MD

Jun 2

4 min read

Chikungunya Vaccine Candidate Heads to Phase 3 Study

Valneva chikungunya vaccine candidate VLA1553 reduces clinical illness risk

asian beach scene

Fact checked by Robert Carlson, MD

Mar 25

4 min read

Chikungunya Vaccine Approaches Phase 3 Study

Valneva VLA1553 vaccine is critical as the chikungunya virus is considered a public health threat

mosquito

Fact checked by Robert Carlson, MD

Jan 14

4 min read

Chikungunya Vaccine Candidate To Begin Testing in Europe

Emergent BioSolutions’ CHIKV-VLP vaccine is being developed for the prevention of disease caused by a chikungunya virus infection

antwerp belgium office building

Tropical Diseases

Fact checked by Robert Carlson, MD

Nov 18

4 min read

Chikungunya Vaccine Candidate Delivered Excellent Study Results

Valneva chikungunya vaccine candidate VLA1553 was generally safe in all dose groups and the local tolerability profile was excellent

mountain hiker